Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009895292
Ticker AZN
Company ASTRAZENECA
Currency $
Price
Aware Investor Index (AII) 143.0185
Recommendation STRONG BUY
P/E 6.94
ROE 29.16 %
Capitalization 37,444,000,000 $
Dividend Yield 9.46 %
P/S 1.58
AII Position 28
P/E Position 20
ROE Position 102
Capitalization Position 226
Dividend Yield Position 8
Sales 23,641,000,000 $
10-Year Average Earnings 5,396,600,000 $
Shares Outstanding 1,265,000,000
Equity 18,509,000,000 $
Dividend per Share 2.8 $
Industry Pharmaceutical
Country Great Britain
ASTRAZENECA Investor Relations Web Site http://www.astrazeneca.com/Investors







Sales:

YEAR MONTH AMOUNT
2015 12 23,641,000,000.00 $
2014 12 26,095,000,000.00 $
2013 12 25,711,000,000.00 $
2012 12 27,973,000,000.00 $
2011 12 33,591,000,000.00 $
2010 12 33,269,000,000.00 $
2009 12 32,804,000,000.00 $
2008 12 31,601,000,000.00 $
2007 12 29,559,000,000.00 $
2006 12 26,475,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 2,488,000,000.00 $
2014 12 -271,000,000.00 $
2013 12 2,458,000,000.00 $
2012 12 6,405,000,000.00 $
2011 12 9,470,000,000.00 $
2010 12 8,106,000,000.00 $
2009 12 7,490,000,000.00 $
2008 12 6,130,000,000.00 $
2007 12 5,627,000,000.00 $
2006 12 6,063,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 18,509,000,000.00 $
2014 12 19,646,000,000.00 $
2013 12 23,253,000,000.00 $
2012 12 23,952,000,000.00 $
2011 12 23,472,000,000.00 $
2010 12 23,410,000,000.00 $
2009 12 20,821,000,000.00 $
2008 12 16,060,000,000.00 $
2007 12 14,915,000,000.00 $
2006 12 15,416,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 1,265,000,000
2014 12 1,264,000,000
2013 12 1,254,000,000
2012 12 1,261,000,000
2011 12 1,367,000,000
2010 12 1,446,000,000
2009 12 1,450,000,000
2008 12 1,453,000,000
2007 12 1,495,000,000
2006 12 1,564,000,000

 












Bloomberg News for ASTRAZENECA:

Apr 27, 2017
Total's Profit Beats Estimates as French Giant Plans Growth
lot of weak players.”Other developments that could be sanctioned in the period include Azerbaijan’s Absheron license, in which Total just increased its stake. Total recently bought interests in the...
Apr 27, 2017
Saudis Seen Losing Market Share to Iran, Iraq on Oil Cuts
Saudi Minister of Energy and Industry Khalid Al-Falih told reporters Wednesday in Baku, Azerbaijan. Al-Falih said he’ll talk with his Russian counterpart Alexander Novak by phone this week and meet...
Apr 26, 2017
OPEC Ministers to Meet Russia Amid Push to Extend Cuts
OPEC nations and other non-members, the state-run Algerian Press Service reported.Azerbaijan, another participant in last year’s deal, also supports prolonging the supply curbs, Al-Falih said after...
Apr 26, 2017
Oil Seen at or Below $40 If OPEC Doesn't Extend Output Cuts
extended, Saudi Minister of Energy and Industry Khalid Al-Falih told reporters in Baku, Azerbaijan.An extension by OPEC and nations outside the group is already priced into oil markets, said Robin...
Apr 25, 2017
Putin's Arms Bazaar Is in a Serious Sales Slump
planes, but are hardly on a spending spree because their own oil revenue has dried up. Azerbaijan, a top customer, cut arms imports by 36 percent. Iran, even freed of many Western sanctions after an...
Apr 20, 2017
The Bond Market Prefers Dictators to Democracies
as “free.”Non-democratic states can take many forms, according to Freedom House. In Azerbaijan, President Ilham Aliyev succeeded his father and has clung to power via three questionable elections...
Apr 6, 2017
Kuwait Is Best Off, Nigeria Worst in Fitch's 2017 Oil Break-Even
$84Angola at $82Oman at $75Saudi Arabia at $74Russia at $72Kazakhstan at $71Gabon at $66Azerbaijan at $66Iraq at $61Abu Dhabi, United Arab Emirates, at $60Republic of Congo at $52Qatar at $51Kuwait...
Apr 6, 2017
Trump's Tightrope in Syria Is Getting Shakier
chiefs of the two nations' staffs, Joe Dunford and Valery Gerasimov, met in Baku, Azerbaijan -- the first such top-level military meeting since Russia annexed Crimea in 2014. Last month, they added...
Apr 3, 2017
Ruling Party Sweeps Armenian Elections as Power Shift Looms
fresh concern and new worries” against a “backdrop of deep discontent, economic crisis and the looming threat of renewed hostilities” with neighboring Azerbaijan over the disputed territory of Nagorno-Karabakh...
Mar 29, 2017
Boeing Makes Billion-Dollar Bet on 747 Hauling Cargo, Not People
out the massive, hump-backed 747s to cargo carriers in countries such as Russia and Azerbaijan, which increases the company’s exposure to potential defaults on payments.Through the end of last year...


Google News for ASTRAZENECA:

Market Exclusive - 8 hours ago
AstraZeneca plc (NYSE:AZN) reported earnings of $0.99 per share ...
AstraZeneca plc (NYSE:AZN) reported 3/31/2017 earnings this Morning, coming in at $0.99 per share, beating Wall Street's estimates of $0.41 ...
Wolcott Daily
AstraZeneca sales fall further as generic competition bites deep (AZN)
LONDON, April 27 (Reuters) - AstraZeneca, struggling with loss of patents on blockbusters like cholesterol pill Crestor, reported another quarter ...
Transcript Daily
What Analysts Recommend for AstraZeneca
Wall Street analysts estimate that AstraZeneca's (AZN) top line will rise 8.0% to ~$4,742 million in 1Q17. Also, the earnings per share are ...
Markets Daily
Stock On the Run: AstraZeneca PLC (AZN)
Leerink Swann Upgrades AstraZeneca PLC (AZN)'s stock to Outperform with no specific Price Target. This rating was issued on 12/09/16.
Markets Insider - 15 hours ago
Outlook for AstraZeneca uncertain say analysts
Morgan Stanley: Earnings beat led by externalization revenue and higher-than-expected cost savings in core business, won't be sustainable ...
MarketWatch
AstraZeneca plc (AZN) Shares Cross Below 200 DMA
In trading on Monday, shares of AstraZeneca plc (Symbol: AZN) crossed below their 200 day moving average of $30.06, changing hands as ...
Nasdaq
AstraZeneca Core Earnings Rise Despite Sales Slide; Key Trial Eyed
AstraZeneca (AZN) is pinning its hopes on immuno-oncology — rivaling Merck (MRK), Bristol-Myers Squibb (BMY) and Roche (RHHBY) ...
The Pharma Letter (registration)
Earnings Per Share of $0.38 Anticipated For Astrazeneca PLC ...
Research analysts are predicting that Astrazeneca PLC (NYSE:AZN) will report earnings of $0.38 per share when the firm issues their quarterly ...
Market Realist - 1 day ago
Jefferies Downgrades AstraZeneca (AZN) to Hold; Sees Bristol ...
Jefferies downgraded AstraZeneca (NYSE: AZN) from Buy to Hold. ... While they also see AZN as a potential consolidation target, its IO portfolio ...
HugoPress - 13 minutes ago
Synairgen loses half its value as AstraZeneca dumps drug
L> lost nearly half its value on Thursday as partner AstraZeneca <AZN.L> pulled the plug on an experimental drug designed to help patients ...


Back